GL1X · GenesisL1 explorer

Research workbench

X-ray crystal structure analysis of the catalytic domain of the oncogene product P21H-RAS complexed with caged GTP and mant dgppnhp

Analyse X-ray crystal structure analysis of the catalytic domain of the oncogene… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1GNP
Type
protein
Length
166 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C-H-RAS P21 protein
UniProt
P01112
Ligands
AGN, MG
Pockets
1 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AC-H-RAS P21 proteinprotein16636% helix, 27% strandP01112

Ligands and binding sites

  • AGN · Phosphoaminophosphonic acid 3'-O-(N-methylanthraniloyl-2'-deoxyguanylate ester · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11910.480.7631AGN

Compared structures

  • 1GNP · X-ray crystal structure analysis of the catalytic domain of the oncogene product P21H-RAS… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.